Info on Drugs in Commercial Distribution Sent to OMB
07/19/2004
Federal Register Notice: FDA is announcing that a proposed information collection, “Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution — (21 CFR Part 207)” has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. To view this notice, click here.
